Bionomics Limited (BNOX)
NASDAQ: BNOX · Real-Time Price · USD
0.295
+0.017 (5.97%)
At close: Nov 22, 2024, 4:00 PM
0.292
-0.002 (-0.78%)
After-hours: Nov 22, 2024, 7:43 PM EST
Bionomics Employees
As of June 30, 2024, Bionomics had 24 total employees, including 8 full-time and 16 part-time employees.
Employees
24
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$451,016
Market Cap
5.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 85 |
| Check-Cap | 85 |
| Mainz Biomed | 71 |
| Biomerica | 64 |
| Predictive Oncology | 35 |
| Purple Biotech | 20 |
| Portage Biotech | 7 |
BNOX News
- 14 days ago - Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement - GlobeNewsWire
- 18 days ago - Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program - GlobeNewsWire
- 4 weeks ago - Bionomics to Present at the ThinkEquity Conference - GlobeNewsWire
- 5 weeks ago - Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewsWire
- 7 weeks ago - Bionomics Limited announces intention to re-domicile to the United States - GlobeNewsWire
- 2 months ago - Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder - GlobeNewsWire
- 4 months ago - Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024 - GlobeNewsWire